Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

41.96
BATS BZX Real-Time Price
As of 10:19am ET
 -1.29 / -2.98%
Today’s Change
23.64
Today|||52-Week Range
46.81
+36.15%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close43.25
Today’s open42.55
Day’s range41.69 - 43.20
Volume21,016
Average volume (3 months)277,933
Market cap$1.5B
Dividend yield--
Data as of 10:19am ET, 06/28/2017

Growth & Valuation

Earnings growth (last year)+21.43%
Earnings growth (this year)+27.27%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+25.14%
P/E ratio110.4
Price/Sales10.05
Price/Book8.67

Competitors

 Today’s
change
Today’s
% change
ARRYArray Biopharma Inc+0.04+0.47%
FOLDAmicus Therapeutics ...+0.02+0.21%
INVAInnoviva Inc+0.20+1.59%
EBSEmergent BioSolution...+0.40+1.20%
Data as of 10:21am ET, 06/28/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.15
Annual revenue (last year)$104.5M
Annual profit (last year)$11.7M
Net profit margin11.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts